Results 111 to 120 of about 5,281 (177)

Oral Urate-Lowering Therapy Use and Efficacy Following Pegloticase Treatment: Findings from a Rheumatology Network Database. [PDF]

Rheumatol Ther
Padnick-Silver L, Concoff A, Gao HY, Fu Q, LaMoreaux B, Edwards NL.   +5 more
europepmc   +1 more source

A single-centre experience of febuxostat as a second-line urate-lowering therapy. [PDF]

Malays Fam Physician, 2021
Ong SG, Ding HJ.
europepmc   +1 more source

Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis. [PDF]

Ther Adv Musculoskelet Dis, 2021
Sharma G, Dubey A, Nolkha N, Singh JA.
europepmc   +1 more source

Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis. [PDF]

Front Pharmacol, 2021
Zhang L, An K, Mou X, Zhang M, Su Q, Li S.   +5 more
europepmc   +1 more source

Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]

Rheumatology (Oxford)
Uhlig T, Karoliussen LF, Sexton J, Provan SA, Haavardsholm EA, Dalbeth N, Hammer HB.   +6 more
europepmc   +1 more source

Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. [PDF]

Arthritis Res Ther, 2022
Guma M, Dadpey B, Coras R, Mikuls TR, Hamilton B, Quehenberger O, Thorisdottir H, Bittleman D, Lauro K, Reilly SM, Liu-Bryan R, Terkeltaub R.   +11 more
europepmc   +1 more source

Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares. [PDF]

Rheumatology (Oxford)
Russell MD, Ameyaw-Kyeremeh L, Dell'Accio F, Lapham H, Head N, Stovin C, Patel V, Clarke BD, Nagra D, Alveyn E, Adas MA, Bechman K, de la Puente MA, Ellis B, Byrne C, Patel R, Rutherford AI, Cantle F, Norton S, Roddy E, Hudson J, Cope AP, Galloway JB.   +22 more
europepmc   +1 more source

Depressive Symptoms and the Effectiveness of a Urate-Lowering Therapy in a Clinical Trial. [PDF]

ACR Open Rheumatol, 2020
Mrug S, Orihuela C, Rahn E, Mudano A, Foster J, Saag K, Gaffo A.   +6 more
europepmc   +1 more source

Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. [PDF]

Front Pharmacol, 2022
Liang X, Liu X, Li D, Qin W, Liu Y.
europepmc   +1 more source

Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study. [PDF]

J Inflamm Res
Jiang C, Li M, Chen Y, He Y, Li X, Cui L, Qi H, Cheng Z, Zhang X, Li C, Lu J.   +10 more
europepmc   +1 more source